Cladribine
Myeloid Neoplasm
University of WashingtonSmall moleculePhase 2Active
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 89/ 100
Competitive context
29 Active assets in the Myeloid Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid First Affiliated Hospital of Zhejiang University | Phase 3 | BBB |
Mitoxantrone First Affiliated Hospital of Zhejiang University | Phase 3 | BBB |
Cyclophosphamide Prelude Therapeutics | Phase 3 | BB |
METHOTREXATE St. Jude Children's Research Hospital | Phase 3 | BB |
Idarubicine Northwestern University | Phase 3 | BB |
View all 49 →
Same molecule, other indications
Cladribine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →